Regulatory Risk: Pharmaceutical sector — clarification on approach to market definition for prescription medicines

SUMMARY - A decision handed down by the UK Court of Appeal earlier this month provides useful guidance on the correct approach to defining the market in relation to pharmaceutical products. The Court of Appeal held that a patented pharmaceutical...
By: DLA Piper

DLA Piper